جست‌وجوی استاد و پژوهشگر

James McDonaldمشاهده پروفایل

مدرس

• Water Treatment
• Membrane Technology
• Trace Organic Contaminants
• +۶ مورد دیگر

Dr. James McDonald serves as a Lecturer and Research Fellow at the University of New South Wales (UNSW) within the School of Civil and Environmental Engineering's Water Research Centre (WRC). His work at the Vallentine Annexe (H22), Room 102, Kensington Campus focuses on advancing water treatment technologies and understanding contaminant behavior in water systems. His position bridges academic instruction with cutting-edge research in environmental engineering. McDonald's research spans multiple critical areas in water science and engineering, with particular emphasis on trace organic contaminants, membrane technologies, and advanced water treatment processes. His work investigates the fate and removal of pharmaceuticals, personal care products, and industrial chemicals in various water treatment systems. He has made significant contributions to understanding disinfection by-product formation, chiral inversion of pharmaceuticals, and the development of novel membrane technologies for improved water purification. His research combines experimental approaches with computational modeling to address complex water quality challenges. Analysis of McDonald's recent publications reveals a strong focus on emerging contaminants, particularly PFAS compounds and chiral pharmaceuticals, and their behavior in water treatment systems. His work demonstrates expertise in both conventional and advanced water treatment technologies, with increasing emphasis on sustainable approaches including green infrastructure and novel membrane processes. The interdisciplinary nature of his research connects environmental engineering, chemistry, microbiology, and materials science to address contemporary water quality challenges. McDonald actively collaborates with researchers across multiple institutions and has contributed to numerous significant studies on water quality and treatment. His work supports the development of more effective water recycling systems and safer drinking water supplies. While specific grant information isn't detailed in the available text, his extensive publication record suggests sustained research funding in water treatment technologies and contaminant fate studies. As part of UNSW's Water Research Centre, McDonald contributes to one of Australia's leading water research facilities. The WRC provides a collaborative environment for addressing complex water challenges through interdisciplinary research that integrates engineering, chemistry, and environmental science perspectives.

Amin Keramatiمشاهده پروفایل

استادیار

• Transportation & Logistics
• Supply Chain Management
• Data Analytics
• +۴ مورد دیگر

Dr. Amin Keramati is an Assistant Professor of Supply Chain Management at Widener University’s School of Business Administration. He holds a PhD in Transportation & Logistics from North Dakota State University and previously served as a graduate research assistant at the Upper Great Plains Transportation Institute. His work includes federally funded projects like the Mountain-Plains Consortium’s MPC-550 project, focusing on highway-rail grade crossing safety. Dr. Keramati teaches courses in enterprise resource planning, decision analytics, database management, transportation/logistics, project management, and data analytics. Education: PhD in Transportation & Logistics, North Dakota State University Graduate Research Assistant at Upper Great Plains Transportation Institute Research Focus: Dr. Keramati develops mathematical, statistical, and machine learning approaches to solve complex problems in transportation, supply chain, and logistics. Key areas include data mining, big data decision support, transportation network analytics, project scheduling, smart manufacturing, and accident analysis. His interdisciplinary work bridges supply chain optimization with emerging technologies like blockchain for healthcare and clinical trials. Awards & Recognition: Student Paper Award, American Association of State Highway and Transportation Officials (2017) Grants & Projects: Lead researcher on the Mountain-Plains Consortium’s MPC-550 project, which expanded his dissertation work on safety systems for highway-rail crossings. Collaborates on federally funded transportation safety initiatives and supply chain optimization for bioethanol and pharmaceutical industries. Labs/Teams: Active in Widener’s School of Business research groups focusing on supply chain innovation and interdisciplinary projects combining logistics with emerging technologies.

Byron Wallaceمشاهده پروفایل

دانشیار

• Natural Language Processing
• Machine Learning
• Artificial Intelligence
• +۵ مورد دیگر

Byron Wallace is the Sy and Laurie Sternberg Interdisciplinary Associate Professor at Northeastern University's Khoury College of Computer Sciences, where he also serves as Associate Dean for Research and Director of the BS in Data Science Program. His research focuses on Natural Language Processing and Machine Learning applications in healthcare. Education Details of formal education are not explicitly provided in the available text, though he holds a PhD from Tufts University (mentioned in thesis award context). Research Interests His work centers on developing NLP and ML models for health applications, with particular emphasis on: Biomedical evidence synthesis automation Electronic Health Record processing Model interpretability and trustworthiness Human-in-the-loop systems Learning with limited supervision Research Trends Recent publications demonstrate strong focus on large language model applications in healthcare, including factuality evaluation for medical summarization, evidence extraction from clinical trials, and interpretable risk prediction models. Notable contributions include work on GPT-3 applications in medical evidence synthesis and neural methods for EHR analysis. Scientific Awards ACL Outstanding Paper Award (2022) ICLR Spotlight (top 5% acceptance) (2024) Best Student-led Paper Award at AMIA 2021 NSF CAREER Award (2018-2023) Advising and Grants Currently advises 4 PhD students and has mentored numerous others. Major funding includes: NSF CAREER Award ($500K+) NIH R01 grant for EHR summarization NSF Medium grant for healthcare summarization Support from Army Research Office, Amazon, and Seton Hospital Labs and Teams Leads the Evidence Inference project team working on automated biomedical evidence synthesis. Collaborates with Brigham and Women's Hospital, Mass General Hospital, and Reboot Rx for clinical translation of research.

Jimeng Sunمشاهده پروفایل

استاد

• Artificial Intelligence
• Healthcare Analytics
• Drug Discovery
• +۵ مورد دیگر

Dr. Jimeng Sun is a Health Innovation Professor at the Siebel School of Computing and Data Science and Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign. Co-founder of Keiji AI , he leads groundbreaking research at the intersection of artificial intelligence and healthcare, actively deploying clinical AI systems and developing frameworks like PyHealth and Therapeutics Data Commons . His research spans four major areas: Clinical AI Systems : Developing interpretable models (e.g., RETAIN) for patient similarity, temporal event prediction, medication recommendation, and clinical outcome forecasting Drug Discovery : Creating molecular optimization frameworks, drug-target interaction models, and AI-driven platforms Clinical Trials : Pioneering patient-trial matching, outcome prediction, and optimization frameworks using deep learning and graph neural networks Biosignal Analysis : Advancing sleep staging, seizure classification, and automated EEG/Cardiac monitoring systems With over 500 top-tier publications (including in Nature , NEJM AI , and leading AI conferences) and an h-index of 99, his work has been recognized with the Top 100 AI Leaders in Drug Discovery and Advanced Healthcare award. He maintains active collaborations with institutions like Massachusetts General Hospital , Medidata Solutions , and OSF Healthcare . His recent publications reveal a strong focus on: Reinforcement learning applications in medical data analysis Large language model adaptation for clinical tasks Knowledge graph integration with AI systems Synthetic data generation for healthcare Multi-modal learning in clinical contexts Explainable AI for medical applications Dr. Sun's lab ( Sunlab ) emphasizes practical impact over theoretical work, actively collaborating with hospitals and healthtech companies. He welcomes contributions from clinicians, researchers, and industry partners through initiatives like his AI for Health webinar series .

Osman Yağanمشاهده پروفایل

استاد پژوهشی

• Machine Learning
• Data Science
• Network Science
• +۷ مورد دیگر

Osman Yağan is a Research Professor in the Department of Electrical and Computer Engineering at Carnegie Mellon University (CMU), with affiliate faculty status in the School of Computer Science. He is also a core member of CyLab Security and Privacy Institute. Prior to joining CMU in 2013, he was a Postdoctoral Research Fellow at CyLab. He holds a Ph.D. in Electrical and Computer Engineering from the University of Maryland (2011) and a B.S. from Middle East Technical University (2007). His research focuses on modeling, analysis, and optimization of computing systems, leveraging applied probability, network science, data science, and machine learning. Key areas include multi-armed bandits, resilient machine learning, contagion processes in networks, and cybersecurity. Research Interests include Machine Learning, Data Science, Network Science, Cybersecurity, and Robustness in Cyber-Physical Systems. He has advised numerous students, including current PhD candidates Yurun Tian, Orkun İrsoy, and Ishank Juneja, as well as notable alumni such as Mansi Sood (now at MIT) and Jun Zhao (Assistant Professor at Nanyang Technological University). Key Awards include the CIT Dean's Early Career Fellowship, IBM Academic Award, and Best Paper Awards at ICC 2021, IPSN 2022, and ASONAM 2023. His work spans theoretical contributions (e.g., contagion models in multi-layer networks) and applied research (e.g., mitigating cascading failures in power systems). He leads or co-leads grants from ONR, NSF, and ARO, focusing on resilient machine learning, network robustness, and pandemic modeling.

• Public Economics
• Industrial Organization
• Government Procurement
• +۳ مورد دیگر

Rodrigo Carril is an Assistant Professor at the Department of Economics and Business at Universitat Pompeu Fabra (UPF) and an Affiliated Professor at the Barcelona School of Economics (BSE). His research focuses on Public Economics and Industrial Organization, particularly examining public procurement policies and their economic impacts. He holds a PhD in Economics from Stanford University (2020) and is a Juan de la Cierva Researcher. Education: PhD in Economics, Stanford University (2020). His work explores topics such as pharmaceutical market dynamics, defense contracting efficiency, and regulatory frameworks for public procurement. He has received prestigious awards including the Claire and Ralph Landau Prize (2020) and the Young Economists' Essay Award (2022). Key research trends include analyzing procurement policies' effects on competition, evaluating preference programs for disadvantaged groups, and methodological contributions to econometric techniques like regression discontinuity designs. Awards: Claire and Ralph Landau Prize 2020 Young Economists' Essay Award 2022 Advising and Grants: While specific grants aren’t listed, his collaborative work involves co-authors like Claudia Allende, Mark Duggan, and Andres Gonzalez-Lira, indicating active academic partnerships. He is affiliated with the BSE and contributes to policy-oriented research initiatives. Labs/Teams: Engaged in interdisciplinary projects at UPF and BSE, focusing on public sector efficiency and regulatory economics.

• Advanced water treatment processes
• Membrane processes
• Ozonation
• +۱۳ مورد دیگر

Prof. Dr. Jörg E. Drewes is a Full Professor and Chair at the Research Institute for Urban Water Management, Technical University of Munich (TUM), Germany. He also serves as Academic Program Director for Environmental Engineering at TUM and is a co-founder of Waterloop Solutions GmbH. His work spans advanced water treatment technologies, wastewater reuse, and environmental health surveillance. Affiliations : TUM, Colorado School of Mines, King Abdullah University of Science and Technology, UNSW Water Research Centre Research focuses on advanced oxidation processes , membrane fouling mitigation , micropollutant removal , and wastewater epidemiology for public health. His team develops integrated systems for water-energy-food nexus applications and graphene oxide-based treatment solutions. Recent publications address PFAS remediation , UVC-LED pre-treatment for biofouling control, and GIS-based wastewater surveillance models . Awards include the Bayerische Staatsmedaille (2023) and William Dunbar Medal (2022). 2023 : Bayerische Staatsmedaille 2022 : William Dunbar Medal 2018 : IWA Fellow He leads the Nexus@TUM initiative and contributes to EU water resilience strategies. Collaborations include projects in Germany, China, India, and Spain, focusing on climate-resilient water systems and resource recovery .

Daniel Finleyمشاهده پروفایل

استاد

• Ubiquitin-Proteasome Pathway
• Proteostasis
• Protein Degradation
• +۷ مورد دیگر

Daniel Finley is a Professor of Cell Biology at Harvard Medical School (HMS), leading the Finley Lab focused on the ubiquitin-proteasome pathway and related regulatory mechanisms. He holds academic appointments within the Department of Cell Biology and sits on the Scientific Advisory Boards of Proteostasis and X-Chem Pharmaceuticals. His research investigates proteasome function, ubiquitin-like proteins, and proteostasis roles in diseases like Alzheimer’s and ALS. Dr. Finley earned his undergraduate degree in biochemistry from Harvard University and a Ph.D. in molecular biology from MIT. After postdoctoral training at MIT, he joined HMS in 1988. His lab explores topics including erythroid proteome remodeling, mitochondrial dysfunction, and neurodegenerative disease mechanisms. Key research areas include: (1) Ubiquitin-proteasome pathway regulation, (2) Proteasome structure/function, (3) Nonproteolytic roles of ubiquitination, and (4) Pathophysiological roles of proteostasis defects in diseases. His work bridges basic cell biology with translational medicine, particularly in neurodegeneration and anemia. Finley has secured NIH funding for projects like 'Regulation of Proteasome Activity' (R35GM145246) and 'Erythrocyte maturation through global proteome remodeling' (R01HL153970). Collaborations with industry and academic partners extend his impact in drug discovery and proteasome-targeted therapies. His lab’s contributions include defining ubiquitin chain editing mechanisms, identifying USP14’s role in mitophagy, and elucidating proteostasis defects in Alzheimer's models. Research tools developed include advanced cryo-EM analyses of proteasomal structures and functional assays for ubiquitin system enzymes.

Stefanos Zeniosمشاهده پروفایل

استاد

• Operations Research
• Innovation
• Entrepreneurship
• +۳ مورد دیگر

Stefanos Zenios is Professor at Stanford Graduate School of Business with dual appointments in Entrepreneurship and Operations, Information & Technology . He directs Stanford GSB’s Center for Entrepreneurial Studies and co-directs the Doerr School of Sustainability ’s Program in Ecopreneurship. His Startup Garage course has launched companies like DoorDash while alumni have raised over $3B in venture capital. He co-authored the foundational Biodesign textbook and previously served as Editor-in-Chief of Operations Research . PhD, MIT Operations Research (1996) MA, University of Cambridge (1996) BA, University of Cambridge (1992) Research Focus Dr. Zenios’ work bridges operations research and innovation management , with significant contributions to: Healthcare operations : Administrative cost reduction, organ allocation optimization, and clinical workflow improvements Entrepreneurship : Venture creation frameworks and experiential education Ecopreneurship : Sustainable business model innovation His Precedents Thinking framework (HBR 2025) has gained global recognition for solving systemic inefficiencies. Current research includes the biennial Search Fund Study with Peter Kelly. Scientific Recognition INFORMS Fellow Multiple Best Paper Awards, INFORMS CAREER Award, National Science Foundation (2000) Dhirubhai Ambani Faculty Fellow (2017–2020) George E. Nicholson Award (1997) He has received extensive media coverage in Fast Company , Time Magazine , and Stanford Business . His research has been featured in over 150 press mentions including JAMA , Harvard Business Review , and Health Affairs .

Joel Gohمشاهده پروفایل

دانشیار

• Health services and systems
• Transportation, logistics and supply chains
• Operations research
• +۶ مورد دیگر

Joel Goh is Associate Professor at the Department of Analytics and Operations, NUS Business School, National University of Singapore. He serves as Director of the J.Y. Pillay Comparative Asia Research Centre (under NUS Global Asia Institute) and PhD Program Director at the Institute of Operations Research and Analytics (IORA). Previously, he was Assistant Professor at Harvard Business School (2014-2017) and Visiting Scholar (2017-2022). BSc, MSc, PhD in Operations, Information, and Technology from Stanford University His research focuses on healthcare analytics (preventing health conditions, hospital operations, frailty assessment), supply chain analytics (digital business models, platform leakage), and service platform operations (hospital-at-home programs, incentive design). He co-created the Robust Optimization Made Easy (ROME) software. Recent publications analyze workplace psychological safety (2024), hospital-at-home models (2024), and platform leakage dynamics (2023). His work spans 18+ journals with 740+ citations for burnout cost studies (2022) and 606+ citations for physician well-being research (2017). Teaching Honors : 2023: Best MBA Teaching & Skinner Innovation Award 2021: NUS Annual Teaching Excellence Award 2020: Early Career Research Excellence Award & 40 Under 40 Best MBA Professors Advising & Grants : Served as PhD Program Director. Received NUS Start-Up Grant R-314-000-110-133 (2021) and Humanities & Social Sciences Fellowship (2021). Editorial roles include Associate Editor at Management Science , Manufacturing & Service Operations Management , and Senior Editor at Production and Operations Management .

Vikramaditya G. Yadavمشاهده پروفایل

دانشیار

• Biocatalysis
• Bioremediation
• Bioprocess engineering
• +۱۵ مورد دیگر

Vikramaditya G. Yadav is an Associate Professor at the University of British Columbia (UBC) in the Department of Chemical and Biological Engineering, Faculty of Applied Science. He directs the Master of Engineering Leadership (MEL) Program in Sustainable Process Engineering and leads the BioFoundry research group. Education: B.A.Sc., University of Waterloo (2007) Ph.D., Massachusetts Institute of Technology (2013) Postdoctoral Associate, Harvard University (2014) His research spans sustainable chemical manufacturing, metabolic engineering, and biotechnology. Key areas include: Designing biosynthetic enzymes for biomass valorization Developing bioremediation strategies for industrial water quality Creating innovative drug delivery systems and tissue engineering solutions Advancing synthetic biology for pharmaceutical and bioenergy applications His recent work focuses on ocular drug delivery, cannabinoid biosynthesis in E. coli, lignin-based nanoparticles for cancer therapy, and computational analysis of plant secondary metabolites. Collaborations with start-ups, industry, and medical labs drive innovation in Canada's bioeconomy. Professional Leadership: Chair, Biotechnology Division of the Chemical Institute of Canada Associate Editor, The Canadian Journal of Chemical Engineering He is affiliated with UBC's BioProducts Institute and contributes to project-based learning pedagogy.

Erik Gordonمشاهده پروفایل

استادیار بالینی

• Entrepreneurship
• Technology Commercialization
• Venture Capital
• +۱۳ مورد دیگر

Erik Gordon is a Clinical Assistant Professor of Entrepreneurial Studies and Area Chair at the Ross School of Business, University of Michigan. He holds degrees in economics and law, with prior roles including Associate Dean and Director of the Graduate Division of Business & Management at Johns Hopkins University, and leadership positions at the University of Florida’s Center for Technology & Science Commercialization Studies. His research focuses on entrepreneurship, venture capital, private equity, corporate governance, and FinTech. He frequently contributes to media outlets like The New York Times, Bloomberg, and Marketplace, offering insights on business trends and corporate strategy. His teaching spans advanced topics in business strategy, with a focus on real-world application and interdisciplinary approaches. Notable engagements include commentary on the pandemic’s impact on education and virtual teaching methodologies. He advises initiatives like the Wolverine Venture Fund and Zell Early-Stage Fund, emphasizing practical experience for students.

Allison Koeneckeمشاهده پروفایل

استادیار

• Algorithmic Fairness
• Computational Social Science
• Public Health
• +۴ مورد دیگر

Allison Koenecke is an Assistant Professor of Information Science at Cornell Tech and a field faculty member in Computer Science at Cornell University. Previously, she was a postdoctoral researcher at Microsoft Research New England and completed her PhD at Stanford University’s Institute for Computational & Mathematical Engineering. Her research focuses on algorithmic fairness, computational social science, and causal inference in public health, addressing disparities in automated systems like speech recognition and policy decision-making. Education : PhD, Stanford Institute for Computational & Mathematical Engineering MA/MS, Stanford University BA/BS, Massachusetts Institute of Technology Research Interests : Dr. Koenecke’s work bridges economics and computer science, emphasizing equity in AI systems. Key areas include: Algorithmic bias in speech recognition (e.g., racial disparities in voice assistants) Fairness in policy tools like environmental justice data systems Causal analysis in public health interventions Ethical implications of large language models in education Media & Impact : Her research has been featured in outlets like New York Times , Science , and Scientific American . Notable studies include exposing racial gaps in speech-to-text systems and advocating for inclusive dataset development. She also explores societal impacts of AI in education and governance. Awards : Sloan Research Fellow in Computer Science Forbes 30 Under 30 in Science NSF Awards Cornell CIS Teaching Excellence Award (2024) Teaching & Outreach : She teaches courses like Designing Fair Algorithms and Data Science for Global Development , emphasizing interdisciplinary collaboration. Her PhD Professionalization course addresses hidden curricula in academia. She advises on AI ethics for nonprofits, tech companies, and government agencies.

Connor Coleyمشاهده پروفایل

استادیار

• Machine Learning for Chemistry
• Computer-Aided Molecular Design
• Synthesis Planning
• +۵ مورد دیگر

Connor Coley is the Henri Slezynger (1957) Career Development Assistant Professor at the Massachusetts Institute of Technology (MIT) School of Engineering. His research bridges chemistry and machine learning, focusing on autonomous molecular discovery, predictive chemistry, and laboratory automation. Education: Ph.D., MIT (2019) M.S.CEP., MIT (2016) B.S., Caltech (2014) Research Interests: Dr. Coley’s work centers on domain-informed machine learning for chemistry, computer-aided molecular design, and autonomous laboratories. Key themes include predictive modeling of chemical reactivity, optimization of synthesis pathways, and integration of AI with experimental data for drug discovery and materials science. Publications: His recent articles highlight advancements in AI-driven reaction prediction, molecular representation learning, and laboratory automation. Trends include applications of Bayesian optimization, contrastive learning, and diffusion models to chemical discovery. Scientific Awards: Camille Dreyfus Teacher-Scholar Award (2025) James W. Swan Outstanding Faculty (2025) Schmidt Futures AI2050 Early Career Fellow (2022) NSF CAREER Award (2021) Forbes 30 Under 30: Healthcare (2019) Software & Tools: He leads the open-source ASKCOS software suite for synthesis planning, adopted by 35,000+ chemists and deployed at 15+ pharmaceutical companies. His team also develops tools for metabolomics and molecular representation learning.

Paul Stuppleمشاهده پروفایل

استاد

• Small Molecule Drug Discovery
• Cancer Therapeutics
• Pharmaceutical Chemistry
• +۳ مورد دیگر

Prof. Paul Stupple is a Professor of Medicinal Chemistry at Monash University, Australia, with over 20 years' experience in pharmaceutical industry and academia. He holds leadership roles at Canthera Discovery and manages the Australian Translational Medicinal Chemistry Facility. His expertise lies in small molecule drug discovery, particularly targeting cancer therapies and epigenetic regulators. Affiliations: Monash University, Faculty of Pharmacy and Pharmaceutical Sciences Canthera Discovery (Director, Medicinal Chemistry) Education: BA and DPhil in Chemistry from the University of Oxford (1992–1999). Early career at Pfizer as a medicinal chemistry leader, delivering 6 clinical candidates. Key contributions include: Licensing deals with Merck (2016) and Pfizer (2018) for preclinical projects Leading the Cancer Therapeutics CRC's medicinal chemistry program Research Interests: Small molecule drug discovery focused on histone acetyltransferase inhibitors, cancer therapeutics, and epigenetic modulation. Notable projects include development of KAT6A/B inhibitors for ER+ breast cancer and STING agonists for immunotherapy. Grants/Projects: Principal Investigator for major initiatives like MedChem Australia (2023–2028) and drug target identification platforms. Collaborates widely with institutions like WEHI and University of Sydney. Over 28 peer-reviewed publications spanning 1997–2025. Labs/Teams: Oversees the Australian Translational Medicinal Chemistry Facility, a key resource for drug discovery in Australia.